Mizuho Securities Upgrades DepoMed Inc (DEPO) to Buy
Get Alerts DEPO Hot Sheet
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 2
Join SI Premium – FREE
Mizuho Securities upgraded DepoMed Inc (NASDAQ: DEPO) from Neutral to Buy with a price target of $19.00 (from $18.00), on increased takeout probability.
Analyst Irina Koffler commented, "DEPO posted unimpressive numbers in 1Q:16 and shares got dragged down with the group on Friday. We think there is now an attractive entry point into a stock with some positive momentum and takeout prospects ahead, and we upgrade DEPO to Buy from Neutral. Our PT goes to $19 from $18."
She added, "We previously assigned a 20% probability of takeout to DEPO (at $20/share), coupled with 80% reliance on a ~$17/share DCF value. We are shifting to a 50%/50% probability allocation as we progress closer to the Nucynta/ ER settlement."
For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.
Shares of DepoMed Inc closed at $15.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Correction: Citi Upgrades Sirius XM Radio (SIRI) to Neutral
- Sea Ltd. (SE) PT Raised to $85 at Jefferies; 'Solid Execution Across Different Segments'
- Novartis (NOVN:SW) (NVS) PT Raised to CHF95 at JPMorgan
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Hot Upgrades, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!